RISK WARNING: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74% and 89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
RISK WARNING: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Trusted Trading Platform
Free account
Worldwide Trading
Portfolio Management
en
Galapagos WEBP

galapagos Euronext amsterdam

Galapagos NV (GLPG) is a Dutch-Belgian biotechnology company headquartered in Mechelen, Belgium, and listed on Euronext Amsterdam and Nasdaq. The company focuses on the discovery and development of small molecule medicines for inflammatory diseases, fibrosis, and other serious conditions. Its pipeline includes novel therapies targeting conditions such as idiopathic pulmonary fibrosis and inflammatory bowel disease. Galapagos is listed on Euronext Amsterdam. The company is one of Europe's leading biotech firms and a key innovator in the treatment of inflammation and fibrosis. 

 GXE symbol info
 
 


 
Top stories by TradingView
 Technical analysis for GXE
 
GXE chart

Start trading
galapagos now

At In2Markets, we offer unique strategies designed to align with your goals and adapt to changing market conditions. Our team will provide you with real-time support and expert insights to answer your question in a quick and personal way. Whether you’re trading or managing your portfolio, we combine innovation with a personalized approach to ensure you stay ahead.

Update I2M Telefoon (1)